Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Downes

Showing results (251-260 of 295) with videos related to

Pageof 30
Sort By:
Ophthalmology|January 27, 2000
Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclaseK Gregory-Evans, R E Kelsell, C Y Gregory-Evans, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2012
Next-generation sequencing in health-care delivery: lessons from the functional analysis of rhodopsinWayne I L Davies, Susan M Downes, Josephine K Fu, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 25, 2019
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakageThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Frontiers in Medicine|February 14, 2024
Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort studyPeter Kiraly, Immanuel P Seitz, Maram E A Abdalla Elsayed, et al.
Trials|September 23, 2015
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trialMyrte B Breukink, Susan M Downes, Giuseppe Querques, et al.
American Journal of Ophthalmology|February 3, 2020
Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3Thomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
Acta Ophthalmologica|February 10, 2021
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laserThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 6, 2019
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3Thomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
Pageof 30

Showing results (251-260 of 295) with videos related to

Sort By:
Pageof 30
Ophthalmology|January 27, 2000
Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclaseK Gregory-Evans, R E Kelsell, C Y Gregory-Evans, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2012
Next-generation sequencing in health-care delivery: lessons from the functional analysis of rhodopsinWayne I L Davies, Susan M Downes, Josephine K Fu, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 25, 2019
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakageThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Frontiers in Medicine|February 14, 2024
Morphological and functional parameters in X-linked retinoschisis patients-A multicentre retrospective cohort studyPeter Kiraly, Immanuel P Seitz, Maram E A Abdalla Elsayed, et al.
Trials|September 23, 2015
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trialMyrte B Breukink, Susan M Downes, Giuseppe Querques, et al.
American Journal of Ophthalmology|February 3, 2020
Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3Thomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
Acta Ophthalmologica|February 10, 2021
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laserThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|April 6, 2019
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3Thomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
Pageof 30